TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06716775: Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer: a Randomized, Controlled, Open-label Study.

Sponsor: Jiangsu Healthy Life Innovation Medical Technology Co., Ltd · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 200 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT06716775 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06716775 Rescue Dossier →